Johnson & Johnson JNJ
NYSE JNJ
$269.99 -0.22 (-0.08%)
At close: Sep 18, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Income towards Parent Company (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Income towards Parent Company came in at $5.5 billion in Q2 2026, little changed year-over-year from $5.5 billion in Q2 2025, and up 5.71% quarter-over-quarter from $5.2 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Income towards Parent Company (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Income towards Parent Company across 18 years of filings, most recently posting $5.5 billion for Q2 2026.

  • In Q2 2026, Income towards Parent Company changed 0.05% year-over-year to $5.5 billion; the TTM figure through Jun 2026 stood at $21.0 billion (down 7.17% YoY), while the FY2025 annual figure was $26.8 billion, up 90.56% from the prior year.
  • Income towards Parent Company came in at $5.5 billion for Q2 2026 at Johnson & Johnson, up from $5.2 billion in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $26.0 billion in Q4 2023 to a low of -$68.0 million in Q2 2023.
  • Average Income towards Parent Company over 5 years is $5.8 billion, with a median of $4.9 billion recorded in 2022.
  • Year-over-year, Income towards Parent Company plunged 101.34% in 2023 and jumped 4886.76% in 2024.
  • Over 5 years, Income towards Parent Company stood at $4.5 billion in 2022, then retreated by 9.17% to $4.0 billion in 2023, then slipped by 15.26% to $3.4 billion in 2024, then jumped by 49.11% to $5.1 billion in 2025, then increased by 8.17% to $5.5 billion in 2026.
  • Per Business Quant data, the three most recent Income towards Parent Company figures were $5.5 billion in Q2 2026, $5.2 billion in Q1 2026, and $5.1 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 5.53 Bn
Mar 29, 2026 5.24 Bn
Dec 28, 2025 5.12 Bn
Sep 28, 2025 5.15 Bn
Jun 29, 2025 5.54 Bn
Mar 30, 2025 11.00 Bn
Dec 29, 2024 3.43 Bn
Sep 29, 2024 2.69 Bn
Jun 30, 2024 4.69 Bn
Mar 31, 2024 3.26 Bn
Dec 31, 2023 4.05 Bn
Oct 1, 2023 26.03 Bn
Jul 2, 2023 5.14 Bn
Apr 2, 2023 -68.00 Mn
Jan 1, 2023 2.94 Bn
Oct 2, 2022 4.46 Bn
Jul 3, 2022 4.67 Bn
Apr 3, 2022 5.07 Bn
Oct 3, 2021 3.67 Bn
Jul 4, 2021 6.28 Bn